UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 534

Sortiert nach

Accelerated Whole-Breast Irradiation Is Comparable to Conventional Fractionation in Breast Cancer Patients With Adverse Features and Is Gentler in Skin Toxicity

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E39-E39

2016

Link zum Volltext

Verfügbarkeit prüfen

2274 Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer, stage II in 7th TNM but stage I in 6th TNM system?

European journal of cancer (1990), 2015-09, Vol.51, p.S424-S424

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers

European journal of cancer (1990), 2016-12, Vol.69, p.S2-S2

2016

Link zum Volltext

Verfügbarkeit prüfen

1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC)

European journal of cancer (1990), 2015-09, Vol.51, p.S287-S288

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of joint effusion on proprioception in patients with knee osteoarthritis: a single-blind, randomized controlled clinical trial

Osteoarthritis and cartilage, 2011-01, Vol.19 (1), p.22-28

2011

Link zum Volltext

Verfügbarkeit prüfen

8LBA Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinic

European journal of cancer (1990), 2014-11, Vol.50, p.198-198

2014

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

The New England journal of medicine, 2019-07, Vol.381 (4), p.307-316

2019

Link zum Volltext

Verfügbarkeit prüfen

EP-0983 PROGNOSTIC SIGNIFICANCE OF INNER QUADRANT INVOLVEMENT TREATED WITH MASTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY

Radiotherapy and oncology, 2012-05, Vol.103, p.S388-S388

2012

Link zum Volltext

Verfügbarkeit prüfen

5058 POSTER Randomized Phase II Multicenter Trial of Oral Antiangiogenic Agent TSU-68 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline

European journal of cancer (1990), 2011, Vol.47, p.S347-S347

2011

Link zum Volltext

Verfügbarkeit prüfen

AOS10 Prognostic factors for patients with leptomeningeal metastases from solid tumours

European journal of cancer (1990), 2012-04, Vol.48, p.S6-S7

2012

Link zum Volltext

Verfügbarkeit prüfen

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

Annals of oncology, 2017-04, Vol.28 (4), p.855-861

2017

Link zum Volltext

Verfügbarkeit prüfen

5055 POSTER The Palliative CMF is a Reasonable Salvage Treatment Option in Heavily Pretreated Patients With Metastatic Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S346-S346

2011

Link zum Volltext

Verfügbarkeit prüfen

6544 POSTER Chemoradiotherapy for Extrahepatic Bile Duct Cancer With Gross Residual Disease After Surgery

European journal of cancer (1990), 2011, Vol.47, p.S454-S455

2011

Link zum Volltext

Verfügbarkeit prüfen

5042 POSTER Clinical Implications of Palliative Surgery in Patients With Suspicious Versus Proven Metastatic Breast Cancer Under Current Staging System

European journal of cancer (1990), 2011, Vol.47, p.S343-S343

2011

Link zum Volltext

Verfügbarkeit prüfen

PO-0761 PROGNOSTIC FACTORS FOR PATIENTS WITH LEPTOMENINGEAL METASTASES FROM SOLID TUMOR

Radiotherapy and oncology, 2012-05, Vol.103, p.S294-S295

2012

Link zum Volltext

Verfügbarkeit prüfen

Chronic Rejection in a Small Bowel Transplant with Successful Revision of the Allograft by Segmental Resection: Case Report

Transplantation proceedings, 2012-05, Vol.44 (4), p.1180-1182

2012

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant pembrolizumab or placebo + chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/HER2– breast cancer: Results from the phase 3 KEYNOTE-756 study

European journal of cancer (1990), 2024-03, Vol.200, p.113608, Article 113608

2024

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

Annals of oncology, 2020-02, Vol.31 (2), p.246-256

2020

Link zum Volltext

Verfügbarkeit prüfen

Survival Outcome For Breast Cancer Patients With Brain Metastasis: A Multicenter Retrospective Study In Korea (KROG 16-12)

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e716-e716

2020

Link zum Volltext

Verfügbarkeit prüfen

295 (PB-090) - Actual conversion rate from total mastectomy to breast conservation after neoadjuvant chemotherapy for stages II—III breast cancer patients

European journal of cancer (1990), 2018-04, Vol.92, p.S80-S80

2018

Link zum Volltext

Verfügbarkeit prüfen

Actual conversion rate from total mastectomy to breast conservation after neoadjuvant chemotherapy for stages II—III breast cancer patients

European journal of cancer (1990), 2018-04, Vol.92, p.S80

2018

Link zum Volltext

Verfügbarkeit prüfen

6544 The clinicopathologic features and clinical outcomes of gastric cancer initially presented with disseminated intravascular coagulopathy

European journal of cancer supplements, 2009, Vol.7 (2), p.374-374

2009

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic use during the last days of life in cancer patients

European journal of cancer care, 2006-03, Vol.15 (1), p.74-79

2006

Link zum Volltext

Verfügbarkeit prüfen

Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

European journal of cancer (1990), 2018-04, Vol.92, p.S19-S20

2018

Link zum Volltext

Verfügbarkeit prüfen

101 (PB-002) - Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

European journal of cancer (1990), 2018-04, Vol.92, p.S19-S20

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 534

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(449)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(182)
Life Sciences & Biomedicine
(96)
Physical Sciences
(77)
Medicine
(69)
Medicine & Public Health
(67)
Humans
(47)
Technology
(45)
Physics
(36)
Biological And Medical Sciences
(34)
Female
(34)
Exact Sciences And Technology
(28)
Male
(28)
Medical Sciences
(25)
Adult
(24)
Chemistry
(23)
Middle Aged
(22)
Engineering
(21)
Hematology, Oncology And Palliative Medicine
(19)
Immunology
(19)
Dermatology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Accelerated Whole-Breast Irradiation Is Comparable to Conventional Fractionation in Breast Cancer Patients With Adverse Features and Is Gentler in Skin Toxicity

2274 Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer, stage II in 7th TNM but stage I in 6th TNM system?

Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers

1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC)

Effects of joint effusion on proprioception in patients with knee osteoarthritis: a single-blind, randomized controlled clinical trial

8LBA Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinic

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

EP-0983 PROGNOSTIC SIGNIFICANCE OF INNER QUADRANT INVOLVEMENT TREATED WITH MASTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY

5058 POSTER Randomized Phase II Multicenter Trial of Oral Antiangiogenic Agent TSU-68 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline

AOS10 Prognostic factors for patients with leptomeningeal metastases from solid tumours

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

5055 POSTER The Palliative CMF is a Reasonable Salvage Treatment Option in Heavily Pretreated Patients With Metastatic Breast Cancer

6544 POSTER Chemoradiotherapy for Extrahepatic Bile Duct Cancer With Gross Residual Disease After Surgery

5042 POSTER Clinical Implications of Palliative Surgery in Patients With Suspicious Versus Proven Metastatic Breast Cancer Under Current Staging System

PO-0761 PROGNOSTIC FACTORS FOR PATIENTS WITH LEPTOMENINGEAL METASTASES FROM SOLID TUMOR

Chronic Rejection in a Small Bowel Transplant with Successful Revision of the Allograft by Segmental Resection: Case Report

Neoadjuvant pembrolizumab or placebo + chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/HER2– breast cancer: Results from the phase 3 KEYNOTE-756 study

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

Survival Outcome For Breast Cancer Patients With Brain Metastasis: A Multicenter Retrospective Study In Korea (KROG 16-12)

295 (PB-090) - Actual conversion rate from total mastectomy to breast conservation after neoadjuvant chemotherapy for stages II—III breast cancer patients

Actual conversion rate from total mastectomy to breast conservation after neoadjuvant chemotherapy for stages II—III breast cancer patients

6544 The clinicopathologic features and clinical outcomes of gastric cancer initially presented with disseminated intravascular coagulopathy

Antibiotic use during the last days of life in cancer patients

Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

101 (PB-002) - Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

Suchergebnisse filtern